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Toll-like receptors (TLRs) exist on both myeloid and intrinsic
renal cells contributing to the initiation of innate immunity
during renal infection with uropathogenic Escherichia coli.
Toll–interleukin 1 receptor (IL-1R) (TIR)8/SIGIRR is an orphan
receptor of the TLR/IL-1R family, which suppresses TLR
signaling of immune cells and is highly expressed in the
kidney. Lack of TIR8/SIGIRR is associated with enhanced renal
chemokine signaling upon exposure to lipopolysaccharide
(LPS). This was because of TIR8/SIGIRR expression on resident
intrarenal myeloid cells rather than tubular epithelial cells
which express it on basolateral and luminal membranes. The
lack of TIR8/SIGIRR does not enhance TLR/IL-1R signaling in
tubular epithelial cells as was observed in monocytes. TIR8/
SIGIRR is induced in monocytes treated with LPS or tumor
necrosis factor and interferon-c in a dose-dependent manner
but was downregulated in treated tubule epithelial cells. This
cell type-specific regulation and function did not relate to
mRNA splice variants but was associated with N- and O-
glycosylation of the receptor in renal cells of myeloid and
nonmyeloid origin. Our studies show that resident myeloid
cells contribute to TLR-mediated antimicrobial immunity in
the kidney and that this function is controlled by TIR8/SIGIRR.
TIR8/SIGIRR does not suppress TLR signaling in tubular
epithelial cells, which supports their role as sensors of
microbial infection in the kidney.
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published online 2 May 2007
KEYWORDS: SIGIRR; toll-like receptor; lipopolysaccharide; infection
The toll-like receptor (TLR)/interleukin 1 receptor (IL-1R)
superfamily has a central role for initiating innate anti-
microbial immunity and, hence, may contribute to renal
pathology in infective pyelonephritis.1,2 In fact, renal tubular
epithelial cells express TLR1-4 and -11 and can produce
proinflammatory cytokines and chemokines in response to
respective TLR ligands.3–6 Furthermore, renal dendritic cells
contribute to innate immunity in the kidney as they are
activated via TLRs either directly by pathogens or by
endogenous molecules such as Tamm–Horsfall protein.7
Uropathogenic Escherichia coli (UPEC) is the most common
pathogen involved in infective pyelonephritis and UPEC
lipopolysaccharide (LPS) ligates TLR4 as part of the LPS
receptor complex.8 We have recently reported experiments
with TLR4 bone marrow chimeric mice which showed that
TLR4 on intrinsic renal cells as well as on myeloid cells
contributes to renal chemokine signaling and subsequent
renal abcess formation in infective pyelonephritis with
UPEC.9
What are the molecular mechanisms that control renal
TLR signaling? Excessive TLR signaling may lead to severe
inflammation and inappropriate immunity-related tissue
damage.10 In fact, a number of negative regulators of TLRs
have been identified, which include splice variants of
signaling molecules, soluble TLRs, cleavage enzymes, and
receptors of the TLR/IL-1R family, T1/ST2 and toll–IL-
1R(TIR)8/SIGIRR.11–13 The Tir8/Sigirr gene was identified by
searching EST databases for TIR domain-containing se-
quences of yet unknown members of the TLR/IL-1R
family.14,15 TIR8/SIGIRR is the only TIR domain-containing
member of the TLR/IL-1R superfamily that has a single
extracellular immunoglobulin (Ig) domain.14,15 The intracel-
lular domain of TIR8/SIGIRR differs from the typical C
terminus of TLR/IL-1Rs and is similar to that of the
Drosophila toll protein.14 Neither IL-1 nor other ligands
bind to TIR8/SIGIRR. TIR8/SIGIRR does not activate
nuclear factor-kB (NF-kB),14,16 most probably because it
does not retain two amino acids (Ser447 and Tyr536) in the
highly conserved TIR domain.14 TIR8/SIGIRR was proposed
as an endogenous inhibitor of TLR signaling, because
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overexpression of TIR8/SIGIRR in Jurkat or HepG2 cells
substantially reduced IL-1- or IL-18-induced activation of
NF-kB.15,17,18 Tir8/Sigirr-deficient mice are more susceptible
to dextran-induced inflammatory bowel disease and a TIR8/
Sigirr-blocking antibody was shown to aggravate Pseudomo-
nas aeruginosa keratitis in Balb/c mice.19,20 This was referred
to TIR8/Sigirr-mediated suppression of TLR signaling in
dendritic cells, which express TIR8/Sigirr constitutively.
Interestingly, TIR8/Sigirr mRNA is expressed at high levels
in the murine and human kidney in comparison to other
solid organs including lymphoid tissues.15,17 This may either
relate to TIR8/Sigirr expression in intrarenal myeloid cells or
tubular cells. We hypothesized a role for TIR8/Sigirr in
regulating TLR signaling in both cell types during exposure
to UPEC LPS. However, we discovered that renal TLR
signaling is independent of TIR8/Sigirr expression in renal
tubular epithelial cells. Obviously, the regulation and
function of TIR8/Sigirr is different in immune and
nonimmune cells in the kidney.
RESULTS
TIR8/Sigirr is expressed in renal antigen-presenting cells and
renal tubular epithelial cells of 6-week-old C57BL/6 mice
TLR function has been reported to be age-dependent;21
hence, we analyzed TIR8/Sigirr mRNA levels by real-time
reverse transcription (RT)–PCR in C57BL/6 mice, either 10
days, 6 weeks, or 1 year of age. At 6 weeks of age, high levels
of TIR8/Sigirr mRNA were found in kidneys, threefold
compared to respective TIR8/Sigirr levels in spleen (Figure
1a). By contrast, brain, heart, lung, liver, small intestine,
colon, skin, and muscle expressed TIR8/Sigirr mRNA at
lower levels as in spleen. In most organs, TIR8/Sigirr mRNA
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Figure 1 | TIR8/Sigirr expression in C57BL/6 mice. (a) mRNA was extracted from organs of C57BL/6 mice of different age as indicated
(n¼ 3–6). TIR8/Sigirr mRNA expression levels were determined by real-time RT–PCR and expressed as mean of the ratio TIR8/Sigirr /18s-
rRNA7s.e.m.; *Po0.05 vs 1.5 weeks, #Po0.05 vs 6 weeks. (b) TIR8/Sigirr protein expression was determined by Western blot analysis. Proteins
were prepared from kidneys of 6–week-old C57BL/6 wild-type mice or TIR8/Sigirr-deficient mice as indicated. (c) Primary cells were isolated
from of 6-week-old C57BL/6 mice as described in Materials and Methods. TIR8/Sigirr mRNA levels were determined by real-time RT–PCR and
expressed as mean of the ratio TIR8/Sigirr/18s-rRNA7s.e.m. N.d.¼ not detected. (d) F4/80 immunostaining for intrarenal antigen-presenting
cells (black) in kidney cortex (left) and medulla (right). Original magnification  200.
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levels declined from young to old age. Interestingly, TIR8/
Sigirr mRNA levels in 6-week-old C57BL/6 mice were seven-
to eightfold higher as compared to 10-day- or 1-year-old
mice. The prominent expression of TIR8/Sigirr in kidneys of
6-week-old mice was confirmed on the protein level by
Western blot (Figure 1b). Cortex and medulla from kidneys
of 6-week-old C57BL/6 mice expressed equal levels of TIR8/
Sigirr mRNA, suggesting a tubular or interstitial origin rather
than glomerular cells, which predominantely locate to the
renal cortex (data not shown). In fact, unlike primary
mesangial cells tubular epithelial cells and resident CD11b/
F4/80-positive renal myeloid cells both expressed TIR8/Sigirr
mRNA (Figure 1c). The latter cells localize to the interstitium
of the renal cortex and medulla of mice (Figure 1d). These
data indicate that the profound renal TIR8/Sigirr expression
originates from tubular epithelial cells and intrarenal
immune cells, resident antigen-presenting cells.
TIR8/Sigirr localizes to luminal and basolateral membranes of
tubular epithelial cells
The transmembrane molecule TIR8/Sigirr has been reported
to suppress LPS signaling in Jurkat cells by interacting with
the intracellular domain of TLR4 and both extracellular Ig
domain and the intracellular TIR domain of IL-1R.18 Thus,
TIR8/Sigirr should localize to outer membranes of these cells.
In fact, flow cytometry of primary tubular epithelial cells
using a TIR8/Sigirr-specific antibody revealed a robust signal
on the cell surface (Figure 2a). The cellular distribution of
TIR8/Sigirr was confirmed by the immunostaining on
primary tubular epithelial cells. Positive staining signals were
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Figure 2 | TIR8/Sigirr expression in tubular epithelial cells. (a and b) Flow cytometry for TIR8/Sigirr was performed using primary tubular
epithelial cells prepared from (a) wild-type mice and (b) Tir8/Sigirr-deficient mice as indicated. Surface expression of TIR8/Sigirr (black line) is
indicated by a fluorescence shift compared to the isotype control antibody (red line). (c and d) TIR8/Sigirr immunostaining with phycoerythrin-
labeled secondary antibody confirms TIR8/Sigirr expression on the cellular surface in confluent growing primary tubular epithelial cells
prepared from wild-type mice (c). (d) Tubular epithelial cells from Tir8/Sigirr-deficient mice lack respective positive signal. 4,6-diamidino-2-
phenylindole staining cell nuclei in blue (original magnification  400). (e and f) Renal sections were prepared from 6-week-old C57BL/6 wild-
type mice and Tir8/Sigirr-deficient mice and stained for TIR8/Sigirr with a phycoerythrin-labeled secondary antibody. Fluorescein
isothiocyanate-phalloidin stains brush border in proximal tubular epithelial cells and cell–cell contacts in green. (e) A yellow signal is obtained
at basolateral membranes (arrow heads) and brush border (*) as a result of colocalization of red TIR8/Sigirr staining and green phalloidin
staining. (f) The TIR8/Sigirr signal is absent when renal sections taken from Tir8/Sigirr-deficient mice were stained accordingly, original
magnification  400).
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detected at outer membranes only (Figure 2c). The specificity
of positive signals in both methods was demonstrated by
using tubular epithelial cells prepared from Tir8/Sigirr-
deficient mice (Figure 2b and d). TIR8/Sigirr immunostain-
ing on kidney sections prepared from 6-week-old C57BL/6
mice revealed positive staining signals at basolateral and
luminal membranes of tubular epithelial cells (Figure 2e). In
proximal tubular epithelial cells, the colocalization with the
luminal brush border (costainined with fluorescein isothio-
cyanate–phalloidin) was apparent (Figure 2e). Glomeruli
stained negative for TIR8/Sigirr (not shown). Negative
controls included staining of renal sections from Tir8/
Sigirr-deficient mice (Figure 2f), omitting the primary
antibody (not shown) or preabsorbing the primary antibody
with TIR8/Sigirr-overexpressing human embryonic kidney
293 cells (not shown). Thus, TIR8/Sigirr is expressed on
basolateral and luminal membranes of tubular epithelial cells
in the mouse kidney.
TIR8/Sigirr suppresses renal Ccl2 and Cxcl2 production in
response to LPS in resident myeloid cells but not in tubular
epithelial cells
We have previously shown that both resident intrarenal
myloid cells and tubular epithelial cells contribute to renal
TLR4 signaling in infective pyelonephritis with uropatho-
genic Escherichia coli (UPEC).9 Hence, we hypothesized that
lack of TIR8/Sigirr would enhance LPS-induced renal
chemokine release as a result of uncoupling TLR4 signaling
in both cell types. In fact, kidney slices from Tir8/Sigirr-
deficient mice produced much more Ccl2 and Cxcl2 on
exposure to 1 mg/ml UPEC LPS for 24 h (Figure 3a).
However, when we exposed primary tubular epithelial cells
or CD11b-positive renal myeloid cells to LPS, lack of TIR8/
Sigirr was found to enhance LPS-induced Ccl2 or CxCL2
production only in the myeloid cells but not in the tubular
epithelial cells (Figure 3b and c). These data suggest that the
suppressive effect of TIR8/Sigirr on renal TLR4 signaling
relates to TIR8/Sigirr in intrarenal myeloid cells and is
independent of TIR8/Sigirr in tubular epithelial cells.
TIR8/Sigirr does not modulate TLR signaling in tubular
epithelial cells
LPS-induced chemokine expression is mediated through NF-
kB. Because transfection of primary monocytes and tubular
cells with a NF-kB-reporter gene construct was limited by
low cell survival we used a p50 (NLS) antibody to determine
nuclear translocation of NF-kB as a marker of NF-kB
activation. CD11b-positive monocytes and tubular epithelial
cells were stained after 1 h of stimulation with either medium
or LPS. The data obtained were consistent with those
obtained from LPS-induced Ccl2 and Cxcl2 production
(Figure 4a), indicating that LPS-induced TLR signaling is
independent of TIR8/Sigirr in tubular epithelial cells. Next,
we tested whether TIR8/Sigirr affects signaling of TLRs other
than TLR4 in tubular epithelial cells. Spleen monocytes were
used as a positive control for TIR8/Sigirr function. Primary
tubular epithelial cells and spleen monocytes were isolated
either from 6-week-old wild-type or Tir8/Sigirr-deficient
mice. As with the TLR4 ligand LPS, Tir8/Sigirr-deficient
monocytes produced increased amounts of Ccl2 when
exposed to ligands for TLR1/2 (Pam3Cys), TLR3 (poly I:C
RNA), and TLR9 (CpG-DNA) (Figure 4b). In tubular
epithelial cells, lack of TIR8/Sigirr had no such effect and
no response to CpG-DNA was observed, because tubular
epithelial cells do not express TLR9 (Figure 4c). These data
show that TIR8/Sigirr does not affect signaling through TLR
tubular epithelial cells.
TIR8/Sigirr is a suppressor of TLR mRNA in monocytes but not
in tubular epithelial cells
Do the cell type-specific effects of TIR8/Sigirr on TLR
signaling relate to a modulatory effect on TLR expression
levels? To answer this question, TLR1-9 and -11 mRNA
expression levels were determined by real-time RT–PCR from
monocytes and tubular epithelial cells kept under normal
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Figure 3 | TIR8/Sigirr and LPS-induced Ccl2 and Cxcl2 production
in mouse kidneys. (a) Kidney slices, freshly prepared from wild-type
and Tir8/Sigirr-deficient mice, were placed in medium and exposed to
1 mg/ml ultrapure LPS. After 6 h, supernatants were harvested and
Ccl2 (left) and Cxcl2 production (right) were measured by
enzyme-linked immunosorbent assay. Data represent means7s.e.m.
from three independent experiments; *Po0.05 vs medium, #Po0.05
vs TIR8/Sigirrþ /þ . (b and c) Intrarenal myeloid cells were prepared
from 6-week-old wild-type and Tir8/Sigirr-deficient mice by CD11b
magnetic bead isolation and cultured with granulocyte macrophage
colony-stimulating factor as mentioned in Materials and Methods.
Tubular epithelial cells were prepared as before. The cells were
incubated with either 1 mg/ml ultrapure LPS in medium or medium
alone for 24 h. Data represent means7s.e.m. from three independent
experiments; *Po0.05 vs medium, #Po0.05 vs TIR8/Sigirrþ /þ .
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culture conditions. Monocytes expressed all TLRs and lack of
TIR8/Sigirr increased mRNA levels of TLR1 (13-fold), TLR5
(23-fold), TLR6 (sevenfold), TLR7 (eightfold), TLR9 (12-
fold), and TLR11 (23-fold) as compared to monocytes
isolated from wild-type mice (Figure 5a). Lack of TIR8/Sigirr
did not affect mRNA expression of TLR2, -3, -4, and -8 in
monocytes. By contrast, tubular epithelial cells expressed
TLR1-4 and -11 mRNA independent of TIR8/Sigirr (Figure
5b). Apparently, TIR8/Sigirr is a suppressor of TLR1, -5, - 6,
-7, -9, and -11 mRNA expression in monocytes, but has no
effect on the respective TLRs coexpressed by tubular
epithelial cells, that is TLR1 and TLR11.
The regulation of TIR8/Sigirr is cell type-specific
Next, we examined whether LPS or interferon-g (IFN-g)/
tumor necrosis factor (TNF) stimulation suppress TIR8/
Sigirr mRNA levels in monocytes and tubular epithelial cells.
In fact, both LPS and IFN-g/TNF reduced TIR8/Sigirr mRNA
levels in tubular epithelial cells (Figure 6a and b). By contrast,
LPS and IFN-g/TNF both increased TIR8/Sigirr expression in
monocytes in a dose-dependent manner with highest mRNA
levels after 18 h (Figure 6). Together, these data suggest that
constitutive TLR4 signaling consistently suppresses TIR8/
Sigirr mRNA in tubular epithelial cells and monocytes. By
contrast, LPS or cytokine exposure rather upregulates TIR8/
Sigirr in monocytes but not in tubular epithelial cells,
indicating cell type-specific regulation of TIR8/Sigirr.
Monocytes and renal tubular epithelial cells express the same
splice variant of TIR8/Sigirr mRNA but TIR8/Sigirr protein is
differently N- and O-glycosylated in these cell types
Can the different functional role of TIR8/Sigirr in monocytes
and tubular epithelial cells be explained by either the
expression of different splice variants or by different post-
translational modifications? We performed real-time RT–PCR
using primers specific for the intracellular and extracellular
domain of TIR8/Sigirr (Figure 7a). Monocytes and tubular
epithelial cells expressed comparable levels of both the
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Figure 4 | TIR8/Sigirr and TLR signaling. Monocytes and tubular epithelial cells were prepared from 6-week-old Tir8/Sigirr-deficient
or wild-type mice as indicated. (a) After 1 h of stimulation with LPS (1 mg/ml), the cells were stained with a p50 antibody for detection of
NF-kB activation as described in Materials and Methods. Data represent means7s.e.m. of positive nuclei per high power field (hpf);
*Po0.05 vs medium, #Po0.05 vs TIR8/Sigirrþ /þ . (b and c) Cells were stimulated either with medium, Pam3Cys, pI:C RNA, LPS, or CpG-DNA
for 24 h. Ccl2 production was determined in supernatants by enzyme-linked immunosorbent assay. Data represent means7s.e.m. from three
independent experiments; *Po0.05 vs medium, #Po0.05 vs TIR8/Sigirrþ /þ .
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intracellular and extracellular domain of TIR8/Sigirr (Figure
7b). This was confirmed by Northern blot analysis. Total
RNA was extracted from kidneys and spleens from wild-type
and Tir8/Sigirr-deficient mice. The RNA was hybridized with
a P32-labeled full-length probe (data not shown) or a shorter
probe matching the extracellular part of TIR8/Sigirr. A single
TIR8/Sigirr mRNA transcript of 3.5 kB was detected in both
kidney and spleen and no further splice variants were
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detected (Figure 7c). However, cell type-specific functions of
proteins may relate to post-translational modifications. In
fact, Western blot of total kidney protein isolates revealed two
TIR8/Sigirr-specific bands of 75 and 90 kDa (Figure 7d).
Next, we prepared renal cell suspensions and isolated CD11b-
positive myeloid cells and CD11b-negative renal cells of
nonmyeloid origin. The renal myeloid cells expressed the
larger 90 kDa form of TIR8/Sigirr, whereas the nonmyeloid
renal cells predominantely expressed the smaller form of
75 kDa (Figure 7e). Protein size depends on protein
glycosylation. TIR8/Sigirr carries five putative glycosylation
sites and the predicted and actual molecular weight of TIR8/
Sigirr suggest extensive glycosylation.14 We tested the
glycosylation of TIR8/Sigirr in the two types of renal cells
by digesting protein isolates from renal myeloid and
nonmyeloid cells with peptide-N-glycosidase F (PNGaseF).
This glycosidase digests N-linked but not N-glycans
with fucose-linked a1,3 to the Asn-bound N-acetylglucosa-
mine, O-linked oligosaccharides or glycosylphosphatidylino-
sitol lipid anchors from glycoproteins, and hence, allows
the detection of glycosylation variants. PNGaseF treatment
reduced the molecular mass of TIR8/Sigirr in both CD11b-
a
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Figure 7 | TIR8/Sigirr transcripts and TIR8/Sigirr glycosylation. Tubular epithelial cells and spleen monocytes were prepared from
6-week-old Tir8/Sigirr-deficient or wild-type mice. (a) An expression level of TIR8/Sigirr mRNA was determined by using primers specific for
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of wild-type (WT) and Tir8/Sigirr-deficient mice (KO) as described in Materials and Methods. Note a single TIR8/Sigirr transcript of
3.5 kB in spleen and kidney of wild-type mice. (d–f) Western blot analysis was performed on protein isolates derived from total kidney or
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mostly tubular epithelial cells. (d and e) Note that the smaller but predominant of the two TIR8/Sigirr-specific bands seen in total kidney
isolates derives exclusively from CD11b-negative renal cells. The specificity of the bands is indicated by their absence in isolates from
Tir8/Sigirr-deficient mice. (e) PNGase digests the TIR8/Sigirr glycoforms from both cell types to smaller but still different proteins
indicative of cell-type specific N-glycosylation of TIR8/Sigirr. (f) Inhibiting O-glycosylation with benzyl-GalNAc reduces the size of the
smaller glycoform of TIR8/Sigirr in renal CD11b cells but not the larger form of TIR8/Sigirr present in both cell types.
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positive and -negative renal cells (Figure 7e). CD11b-positive
and -negative renal cells both carry TIR8/Sigirr glycosylated
at identical sites, digested by PNGaseF to a 60-kDa protein.
The CD11b-negative (nonimmune) renal cells, however,
contained additional TIR8/Sigirr glycosylation variants that
are digested by PNGaseF to two other variants with a size of
approximately 45 and 50 kDa. Furthermore, we used benzyl-
N-acetylgalactosamine (benzyl-GalNAc, an inhibitor of
O-glycosylation, to investigate the O-glycosylation of TIR8/
Sigirr in renal immune and nonimmune cells. Benzyl-GalNAc
treatment did not change the size of the larger glycoform
of TIR8/Sigirr in renal myeloid and nonmyeloid cells (Figure
7f), hence, the larger TIR8/Sigirr glycoform is not O-
glycosilated. By contrast, exposing renal nonimmune cells
to benzyl-GalNAc reduced the size of the smaller predomi-
nant TIR8/Sigirr glycoform to about 60 kDa, suggestive of O-
glycosylation of this protein (Figure 7f). These data show that
the cell type-specific functions of TIR8/Sigirr in the kidney
do not relate to different splicing but are associated with
different glycosylation variants.
DISCUSSION
This study was motivated by two observations: First, our
previous observation that TLR4 on intrinsic renal cells as well
as bone marrow-derived cells contributes to innate immunity
in infective pyelonephritis9 and second, TIR8/Sigirr, a
negative regulator of TLR/IL-1R signaling was reported to
be expressed at high levels in the kidney.15,17 We hypothesized
that TIR8/Sigirr would control inappropriate TLR signaling
in the kidney and, if so, that TIR8/Sigirr on renal myeloid
and nonimmune intrinsic renal cells would contribute to this
phenomenon. Although we confirmed the first part of our
hypothesis, our data do not support the latter.
TIR8/Sigirr modulates renal Ccl2 production on exposure
to LPS
Our data clearly demonstrate that TIR8/Sigirr suppresses
renal Ccl2 production on exposure to LPS. This is consistent
with the exacerbation of various other inflammatory disease
models that have been induced in Tir8/Sigirr-deficient mice,
for example endotoxic shock,17 dextran-induced colitis,19 and
Pseusomonas aeruginosa keratitis.20 Recognition of LPS in the
kidney may involve various cell types which can broadly be
classified into renal immune cells and nonimmune cells.
Intrarenal immune cells are mainly resident antigen-present-
ing cells which originate from the bone marrow and form a
dense network in the interstitial space that grid the tubular
compartment in the healthy kidney.22,23 Consistent with the
previous description of TIR8/Sigirr’s function in dendritic
cells and monocytes,15,17 we found that TIR8/Sigirr sup-
presses LPS-induced Ccl2 and Cxcl2 production in renal
antigen-presenting cells. Wald et al.17 reported a similar role
for TIR8/Sigirr in renal tubular cells but in their study kidney
cell suspensions were prepared from Tir8/Sigirr-deficient
mice in a mixed genetic background. In this study, we applied
more stringent preparation techniques for primary tubular
cells, as we found that kidney cell suspensions prepared
following the protocol reported by Wald et al.17 are
commonly contaminated by myeloid cells, compromising
conclusions on the role of TIR8/Sigirr in tubular epithelial
cells. By using the protocol reported by Tsuboi et al.3 the
primary tubular epithelial cell population was 495%.
Furthermore, we have now backcrossed Tir8/Sigirr mutants
for six generations to the C57BL/6 background to prepare
monocytes and tubular epithelial cells from mice with a
predicted 495% identical background as compared to wild-
type controls.24,25 In fact, by using a pure tubular epithelial
cell population no impact of TIR8/Sigirr on TLR signaling
could be detected. Obviously, intrarenal antigen-presenting
cells and tubular epithelial cells contribute to renal TLR4
signaling. Although TIR8/Sigirr is expressed by both cell
types, TIR8/Sigirr suppresses TLR signaling only in intrarenal
antigen-presenting cells and not in tubular epithelial cells.
Although reducing TLR signaling in renal antigen-presenting
cells may avoid inappropriate immunity-related tissue injury,
an unrestricted activation of tubular cells may support the
induction of necessary epithelial stress response elements to
cope with microbial infection.
Identification of novel cell type-specific functions and
regulation of TIR8/Sigirr
Intrigued by the lack of suppressive function of TIR8/Sigirr in
tubular epithelial cells, we first excluded alternative splicing
and localized the spatial expression of TIR8/Sigirr protein.
Alternative splicing is common for the members of the IL-
1R/TLR superfamily and their signaling molecules.13,26,27 By
using PCR primers for the extracellular and intracellular
domain as well as Northern blotting, we essentially excluded
alternative splicing of TIR8/Sigirr. TIR8/Sigirr protein
localized to the basolateral and luminal membranes of
tubular epithelial cells consistent with the spatial subcellular
distribution of the other members of the IL-1R family.21
Post-translational modifications such as glycosylation can
also alter the function of immune mediators.28 Furthermore,
N-glycans have been shown to play a general role in protein
folding and sorting in biosynthetic traffic of polarized renal
tubular epithelial cells.29 We confirmed glycosylation of
TIR8/Sigirr by PNGaseF digestion or inhibition of O-
glycosylation and subsequent Western blotting. Interestingly,
PNGaseF digestion produced two glycoforms of TIR8/Sigirr
in the kidney in addition to the single glycoform found in the
spleen and kidney. Obviously, some renal cells express an
additional glycoform of TIR8/Sigirr beyond the glycoform
also found in immune cells. The smaller form of TIR8/Sigirr
found in renal CD11b-negative (mostly tubular epithelial)
cells is O-glycosilated via benzyl-GalNAc, but myeloid cell
TIR8/Sigirr is not. By contrast, both the myeloid and
nonmyeloid cell TIR8/Sigirr was markedly reduced in size
after digestion with PNGaseF, which is suggestive of extensive
N-glycosylation. Thus, TIR8/Sigirr in renal tubular epithelial
cells is N- and O-glycosylated, whereas TIR8/Sigirr in
intrarenal CD11b-positive myeloid cells lacks benzyl-Gal-
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NAc-dependent O-glycosylation. However, the causative role
of such post-translational modifications and their putative
role for the function of the TIR8/Sigirr–TLR signaling
complex remains to be addressed in future studies.
Notably, beyond the cell type-specific role of TIR8/Sigirr
on TLR signaling, TIR8/Sigirr-induced suppression of TLR
expression and the LPS- or IFN-g/TNF-induced regulation of
TIR8/Sigirr itself are different in antigen-presenting cells and
tubular epithelial cells. LPS challenge suppressed TIR8/Sigirr
mRNA in tubular epithelial cells, which is consistent with
downmodulation of renal TIR8/Sigirr mRNA after intrave-
nous injection of 1 mg LPS in mice.15,17 By contrast, LPS and
TNF/IFN-g have opposite effects on TIR8/Sigirr mRNA
expression in spleen monocytes, a finding consistent with the
recent observation of TIR8/Sigirr expression in monocytes of
patients with sepsis.30
In summary, resident renal antigen-presenting cells
contribute to TLR-mediated antimicrobial immunity in the
kidney and this function is controlled by TIR8/Sigirr, an
orphan receptor of the IL-1R family. Thereby, TIR8/Sigirr
inhibits an inappropriate innate immune response in the
kidney. TIR8/Sigirr is also expressed in tubular epithelial
cells, which promote innate immune signaling through a
limited set of TLRs, that is TLR1–4 (and TLR11 in mice).
However, TIR8/Sigirr does neither inhibit TLR signaling nor
reduce TLR expression in tubular epithelial cells supporting
their role as sensors of microbial infection in the kidney.
MATERIALS AND METHODS
Animal studies
Tir8/Sigirr-deficient mice were generated by homologous recombi-
nation of the Tir8 gene as described previously, genotyped, and
backcrossed to the C57BL/6J strain (Charles River, Sulzbach,
Germany) to generation F5.15 Mice were housed in groups of five
mice in filter-top cages with a 12 h dark/light cycle and unlimited
access to food and water. Cages, nest lets, food, and water were
sterilized by autoclaving before use. All experimental procedures
were performed according to the German animal care and ethics
legislation and had been approved by the local government
authorities.
RNA preparation and real-time quantitative (TaqMan)
RT–PCR
Organs were snap-frozen in liquid nitrogen and stored at 801C. RT
and real time RT–PCR from total renal RNA was prepared as
described.3 Controls consisting of ddH2O were negative for target
and housekeeper genes. Oligonucleotide primer (300 nM) and
probes (100 nM) were from PE Biosystems (Weiterstadt, Germany)
(Table 1).
Northern blot analysis
Total kidney and spleen RNA was isolated, analyzed for the
degradation and purity, and separated on a 1% formaldehyde/3-
[N-morpholino]propanesulfonic acid agarose gel using standard
methods. The RNA was transferred on the GeneScreen membrane,
baked, and cross-linked with UV light. The DNA-probes syntheses
were performed using the prime-it random primer-labeling kit
(Stratagene, La Jolla, CA, USA). P32-labeled DNA probes were
complementary to 243 bp N terminus part (cut with HindIII and
BstXI) or the full-length Tir8/Sigirr. Efficacy of probe synthesis was
checked by polyethylenimine (PEI) chromatography. For hybridiza-
tion, QuickHyb hybridization solution was used (Stratagene). The
membranes were exposed on a PhosphorScreen of the Phosphor-
Imager after 24 h.
Western blot analysis
Organs from mice were manually dissected, homogenized in 1 ml
lyses buffer (50 mM Tris–HCl, pH 7.5; 150 mM NaCl; 100mM sodium
orthovanadate, 0.5% sodium deoxycholat, 4% NP-40, 2% Triton
X-100; 5 mM ethylenediaminetetraacetic acid; 300 mM sucrose;
proteases inhibitor tablets Complete (Roche, Penzberg, Germany),
and centrifuged for 45 min at 30 000 g. The supernatant was tested
for the protein concentration. Extracted proteins were incubated in
2 loading buffer for 30 min at 651C, resolved by 12% sodium
dodecyl sulfate–polyacrylamide gel electrophoresis, and transferred
to an Immobilon-P membrane (Millipore, Eschborn, Germany).
After blocking with 1% Western blocking solution (Roche), the filter
was incubated with a goat polyclonal anti-TIR8/Sigirr antibody
(1:1000; R&D Systems, Wiesbaden-Nordenstadt, Germany) over-
night in 0.5% Western blocking solution (Roche). Immune
complexes were visualized using a peroxidase-conjugated donkey
anti-goat IgG antibody (1:10 000; Dianova, Hamburg, Germany) for
1 h in 0.5% Western blocking solution and processed for detection
by enhanced chemiluminescence (Amersham Pharmacia Biotech
Europe, Freiburg, Germany).
Before digestion with PNGaseF (NewEngland BioLabs, Frank-
furt, Germany) protein isolates were denaturized at 1001C for
10 min in buffer containing 0.5% sodium dodecyl sulfate and 0.04
dithiothreitol. Digestion was performed for 1 h at 371C in buffer
containing 0.05 M sodium phosphate pH 7.5, 1% NP-40. benzyl-N-
acetygalactosamine (Sigma, Taufkirchen, Germany) was used as an
inhibitor for O-glycosylation at 4 mM final concentration. The cells
with or without inhibitors were grown on 90 mm dish for 48 h.
Media containing fresh inhibitor (4 mM) were changed two times
during this period.
Flow cytometry
Flow cytometry of primary spleen monocytes and tubular epithelial
cells was performed using the goat polyclonal anti-TIR8/Sigirr
antibody. A polyclonal phycoerythrin-labeled donkey anti-goat
antibody was used for detection (1:1000, Dianova). A goat IgG
(BD Pharmingen) was used as isotype control. Fluorescence-
activated cell sorting analysis was conducted using a FACScalibur
machine and CellQuest software (BD Pharmingen, Heidelberg,
Germany).
Immunostaining
Immunostaining was performed as described previously.9 Staining
for TIR8/Sigirr and F-actin in tubular epithelial cells was performed
on 3.7% formaldehyde-fixed cell monolayer, permeabilized with
0.5% Triton X-100. Polyclonal anti-TIR8/Sigirr antibody (1:200)
and a phycoerythrin-labeled donkey anti-goat IgG (1:500) were used
for detection. Staining for TIR8/Sigirr was performed on acetone-
fixed frozen section using the forementioned polyclonal anti-
SIGIRR antibody (1:1000) with a phycoerythrin-labeled donkey
anti-goat IgG antibody (1:10 000, Dianova) for detection. Costain-
ing for tubular brush border was performed with fluorescein
isothiocyanate–phalloidin (1:200; Invitrogen, Paisley, UK). Staining
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of NF-kB was performed on 3% paraformaldehyde-fixed cell
monolayer. Cell membranes were permeabilized with 0.5% Triton
X-100 in phosphate-buffered saline. A p50 (NLS) antibody (1:100,
Santa Cruz, Heidelberg, Germany) was used for detecting nuclear
translocation of NF-kB.31
Cell culture conditions for primary cells
Antigen-presenting cells were prepared from kidneys as follows.
Kidney cell suspensions were prepared by applying the mashed
kidney on 30 mm preseparation filters (Miltenyi Biotec GmbH,
Bergisch Gladbach, Germany) and CD11b magnetic bead isolation
was performed (Miltenyi Biotec GmbH). After washing, columns
were removed from magnetic field and cells were eluted and plated
(3 105 cells/ml) in 10% fetal calf serum–1% penicillin/streptavidin
(PS-RPMI) medium supplemented with 0.5 ng/ml recombinant
murine granulocyte macrophage colony-stimulating factor (Immu-
noTools, Friesoythe, Germany) and grown till they were 70–80%
confluent. Flow cytometry revealed that of the CD11b-positive cell
population, 75% also stained positive for F4/80 and 45% for CD11c.
Primary tubular cells were prepared from kidneys of 6-week-old
Tir8/Sigirr-deficient or wild-type C57BL/6 mice and grown in
culture according to a standard protocol.3 Monocytes were prepared
from spleens as follows. Whole spleen was isolated, mashed, and
passed through a 30-m steel-wire mesh. Cells were resuspended in
0.83% ammonium chloride and incubated for 5 min at room
temperature. Monocytes were separated from lymphocytes by
adhesion to plastic. Cells were plated in RPMI 10% fetal calf serum
medium on six- or 12-well plates at 1 106 or 5 105 cells/well,
respectively. Cells were treated with medium control or IFN-g
100 U/ml (PeproTech, Rocky Hill, NJ)þTNF 500 U/ml (Immun-
Tools, Firesoythe, Germany) or TLR ligands as follows: TLR1/2:
Pam3Cys 1 mg/ml (Alexis Biochemicals, Gru¨nberg, Germany), TLR3:
pI:C 50mg/ml (Sigma-Aldrich, Taufkirchen, Germany), TLR4:
ultrapure LPS 1 mg/ml (Invivogen, San Diego, CA, USA), TLR9:
CpG-DNA 1668 1 mM (TibMolbiol, Berlin, Germany). Ligands were
preincubated with polymyxin B sulfate (Sigma) (50 mg/ml) to
Table 1 | Probes used for real-time RT–PCR
TLR Accession-number Sequence
TLR1 AF316985 Forward primer: 50-GTCAAAGCTTGGAAAGAATCTGAAG-30
Reverse primer: 50-AATGAAGGAATTCCACGTTGTTTC-30
6 FAM: 50-ATCTTACCCTGAACAATG-30
TLR2 AF124741 Forward primer: 50-CACCGGTCAGAAAACAACTTACC-30
Reverse primer: 50-CAAGATCCAGAAGAGCCAAAGAG-30
6 FAM: 50-AGACAAAGCGTCAAATC-30
TLR3 AF355152 Forward primer: 50-CGAAAGTTGGACTTGTCATCAAATC-30
Reverse primer: 50-ACTTGCCAATTGTCTGGAAACAC-30
6 FAM: 50-CACTTAAAGAGTTCTCCC-30
TLR4 AF110133 Forward primer: 50-TTCAGAACTTCAGTGGCTGGATT-30
Reverse primer: 50-CCATGCCTTGTCTTCAATTGTTT-30
6 FAM: 50-ATCCAGGTGTGAAATT-30
TLR5 AF186107 Forward primer: 50-CCCAGCTTGGATGAAATATCTGTAA-30
Reverse primer: 50-CCCAGTCTTTTCTTCTTGAACACTTA-30
6 FAM: 50-CGGGCACCAGTACT-30
TLR6 AB020808 Forward primer: 50-TGAATGATGAAAACTGTCAAAGGTTAA-30
Reverse primer: 50-GGGTCACATTCAATAAGGTTGGA-30
6 FAM: 50-TGGTGAGTTCTGATAAAA-30
TLR7 AY035889 Forward primer: 50-TGCCACCTAATTTACTAGAGCTCTATCTTTAT-30
Reverse primer: 50-TAGGTCAAGAACTTGCAACTCATTG-30
6 FAM: 50-CCAAGAAAATGATTTTAATAAC-30
TLR8 AY035890 Forward primer: 50-GGATGTTAAGAGAGAAACAAACGTTTT-30
Reverse primer: 50-AAAAGCACGTCAGAATCCATGA-30
6 FAM: 50-AGAACATGGAAAACATG-30
TLR9 NM 031178 Forward primer: 50-CAATCTGACCTCCCTTCGAGTACTT-30
Reverse primer: 50-GCCACATTCTATACAGGGATTGG-30
6 FAM: 50-ATTGCCGTCGCTGCGACCATG-30
Predeveloped TaqMan assay reagents from Applied Biosystems
SIGIRR NM023059 ContextSeq AoD: 50-GAAGAGCCATGGCAGGTGTCTGTGA-30
TLR11 NM205819
AY510704
ContextSeq AoD: 50-AGGAATGCTGTTGTGCAGAAGATCC-30
18s rRNA Predeveloped TaqMan assay reagents
RT–PCR, reverse transcription–polymerase chain reaction; TLR, toll-like receptor.
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neutralize possible LPS contaminations. After various time intervals
6, 12, 18, or 24 h, culture supernatants were collected and cytokine
levels were determined using a commercial enzyme-linked im-
munosorbent assay kit (Ccl2; R&D Systems Inc., Wiesbaden-
Nordenstadt, Germany). RNA from cells was prepared for mRNA
analysis using the Qiagen RNasy mini kit (Qiagen Sciences, Hilden,
Germany). For additional experiments, 50 mg slices were cut from
kidneys of Tir8/Sigirr-deficient or wild-type C57BL/6 mice and
placed in Dulbecco’s modified Eagle’s medium and 10% fetal calf
serum. The kidney slices were stimulated for 6 h with either medium
or 1 mg/ml ultrapure LPS. After 6 h, supernatants were collected and
Ccl2 and Cxcl2 levels were determined by enzyme-linked immuno-
sorbent assay (R&D Systems Inc.).
Statistical analysis
Data were expressed as mean7s.e.m. Comparison between groups
were performed using Student’s t-test. A value of Po0.05 indicated
statistical significance.
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